Aktana Stock

Life sciences data-fueled insights

Sign up today and learn more about Aktana Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

CIBC Innovation Banking


San Francisco CA, US

Total Funding


About Aktana Stock

Aktana helps life science companies get the most out of artificial intelligence (AI) for commercializing their products. The company’s proprietary platform harnesses machine learning algorithms to enable marketing and sales teams to optimize their engagement with prescribing physicians. Aktana supports more than 100 brands and more than half the top 20 pharmaceutical companies worldwide to increase revenue, capitalize on data investments, and drive channel productivity and results. The company’s focus on the life sciences market allows Aktana to understand and incorporate unique market dynamics more deeply than the major AI players. Headquartered in San Francisco, Aktana also has offices in New York, Philadelphia, London, Barcelona, Tokyo, Osaka, and Shanghai.


CIBC Innovation Banking

VTS, Impartner, GoodData, Aktana, Stratifyd

Leerink Transformation Partners

PatientPop, Aktana

Safeguard Scientifics

MediaMath, Syapse, Aktana

Starfish Ventures


Funding History

August 2011$3.0M
May 2012$2.0M
June 2013$5.5M
June 2016$17.6M
September 2018$21.0M
September 2019$20.0M


Chief Executive Officer

David Ehrlich

Chief Customer Officer

James Anderson

Chief Science Officer

Pini Ben-Or

Chief Financial Officer

Colm Callan

Chief Marketing Officer

Clay Hausmann

Chief Technology Officer

Jin Huang


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: